498 related articles for article (PubMed ID: 19817406)
1. Ligand binding and hydration in protein misfolding: insights from studies of prion and p53 tumor suppressor proteins.
Silva JL; Vieira TC; Gomes MP; Bom AP; Lima LM; Freitas MS; Ishimaru D; Cordeiro Y; Foguel D
Acc Chem Res; 2010 Feb; 43(2):271-9. PubMed ID: 19817406
[TBL] [Abstract][Full Text] [Related]
2. Protein folding and aggregation: two sides of the same coin in the condensation of proteins revealed by pressure studies.
Silva JL; Cordeiro Y; Foguel D
Biochim Biophys Acta; 2006 Mar; 1764(3):443-51. PubMed ID: 16480935
[TBL] [Abstract][Full Text] [Related]
3. Pressure-temperature folding landscape in proteins involved in neurodegenerative diseases and cancer.
Cordeiro Y; Foguel D; Silva JL
Biophys Chem; 2013 Dec; 183():9-18. PubMed ID: 23849959
[TBL] [Abstract][Full Text] [Related]
4. Synthetic prions and other human neurodegenerative proteinopathies.
Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
[TBL] [Abstract][Full Text] [Related]
5. Protein Misfolding Cyclic Amplification of Infectious Prions.
Moda F
Prog Mol Biol Transl Sci; 2017; 150():361-374. PubMed ID: 28838669
[TBL] [Abstract][Full Text] [Related]
6. The "Jekyll and Hyde" Actions of Nucleic Acids on the Prion-like Aggregation of Proteins.
Silva JL; Cordeiro Y
J Biol Chem; 2016 Jul; 291(30):15482-90. PubMed ID: 27288413
[TBL] [Abstract][Full Text] [Related]
7.
Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
[TBL] [Abstract][Full Text] [Related]
8. Prions and the potential transmissibility of protein misfolding diseases.
Kraus A; Groveman BR; Caughey B
Annu Rev Microbiol; 2013; 67():543-64. PubMed ID: 23808331
[TBL] [Abstract][Full Text] [Related]
9. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion.
Silva JL; Vieira TC; Gomes MP; Rangel LP; Scapin SM; Cordeiro Y
Methods; 2011 Mar; 53(3):306-17. PubMed ID: 21145399
[TBL] [Abstract][Full Text] [Related]
10. Influence of pH on the human prion protein: insights into the early steps of misfolding.
van der Kamp MW; Daggett V
Biophys J; 2010 Oct; 99(7):2289-98. PubMed ID: 20923664
[TBL] [Abstract][Full Text] [Related]
11. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
Leliveld SR; Stitz L; Korth C
Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
[TBL] [Abstract][Full Text] [Related]
12. Structural insight into the antiprion compound inhibition mechanism of native prion folding over misfolding.
Choi J; Govindaraj RG; Hyeon JW; Lee K; Ma S; Kim SY; Lee J; No KT
Chem Biol Drug Des; 2017 Jun; 89(6):907-917. PubMed ID: 27933736
[TBL] [Abstract][Full Text] [Related]
13. The amino-terminal PrP domain is crucial to modulate prion misfolding and aggregation.
Cordeiro Y; Kraineva J; Gomes MP; Lopes MH; Martins VR; Lima LM; Foguel D; Winter R; Silva JL
Biophys J; 2005 Oct; 89(4):2667-76. PubMed ID: 16040743
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of misfolding of the human prion protein revealed by a pathological mutation.
Sanz-Hernández M; Barritt JD; Sobek J; Hornemann S; Aguzzi A; De Simone A
Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33731477
[TBL] [Abstract][Full Text] [Related]
15. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
Costanzo M; Zurzolo C
Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
[TBL] [Abstract][Full Text] [Related]
16. Prion disease: a deadly disease for protein misfolding.
Chakraborty C; Nandi S; Jana S
Curr Pharm Biotechnol; 2005 Apr; 6(2):167-77. PubMed ID: 15853695
[TBL] [Abstract][Full Text] [Related]
17. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates.
Soto C; Estrada L; Castilla J
Trends Biochem Sci; 2006 Mar; 31(3):150-5. PubMed ID: 16473510
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
19. Prion protein misfolding and disease.
Moore RA; Taubner LM; Priola SA
Curr Opin Struct Biol; 2009 Feb; 19(1):14-22. PubMed ID: 19157856
[TBL] [Abstract][Full Text] [Related]
20. Hydration and packing effects on prion folding and beta-sheet conversion. High pressure spectroscopy and pressure perturbation calorimetry studies.
Cordeiro Y; Kraineva J; Ravindra R; Lima LM; Gomes MP; Foguel D; Winter R; Silva JL
J Biol Chem; 2004 Jul; 279(31):32354-9. PubMed ID: 15173173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
